Venous & Lymphatic Challenges - Tuesday, 26th April
Venue: Kensington 2
Time: 08:00 - 18:00
Appropriate Care Challenges
08:00-10:00
Time: 08:00 - 09:00
Anchor: | Stephen Black, London, United Kingdom |
Moderator: | Armando Mansilha, Porto, Portugal |
08:00 - 08:05
The extent of the ‘overtreatment’ problem in venous disease
Speaker: | Steve Elias, Englewood, United States |
08:05 - 08:10
Audience participation and discussion
08:10 - 08:15
Managing the safe introduction of venous medical devices
Speaker: | Kathleen Gibson, Bellevue, United States |
08:15 - 08:20
Audience participation and discussion
08:20 - 08:25
Prioritisation of venous interventions
Speaker: | Mark Meissner, Seattle, United States |
08:25 - 08:30
Audience participation and discussion
08:30 - 08:35
Value of ESVS venous guidelines for promoting evidence-based care
Speaker: | Marianne De Maeseneer, Reet, Belgium |
08:35 - 08:40
Audience participation and discussion
08:40 - 08:45
How to curtail inappropriate care in venous disease interventions
Speaker: | Manj Gohel, Cambridge, United Kingdom |
08:45 - 08:50
Audience participation and discussion
08:50 - 08:55
The importance of registries in promoting good venous management
Speaker: | Alun Davies, London, United Kingdom |
08:55 - 09:00
Audience participation and discussion
Superficial Venous Challenges
Time: 09:00 - 10:00
Anchor: | Stephen Black, London, United Kingdom |
Moderators: | Erin Murphy, Charlotte, United States |
Manj Gohel, Cambridge, United Kingdom |
09:00 - 09:05
Optimal management of patients with superficial vein thrombosis.
Speaker: | Armando Mansilha, Porto, Portugal |
09:05 - 09:10
Audience participation and discussion
09:10 - 09:15
Venous thromboembolic risk assessment for endovenous interventions
Speaker: | Alun Davies, United Kingdom |
09:15 - 09:20
Audience participation and discussion
09:20 - 09:25
Edited Case: Perforator ablation
Speaker: | Steve Elias, Englewood, United States |
09:25 - 09:30
Audience participation and discussion
09:30 - 09:35
Pros and cons of multimodal, single-stage superficial venous interventions
Speaker: | Marie Josee Van Rijn, Rotterdam, Netherlands |
09:35 - 09:40
Audience participation and discussion
09:40 - 09:45
Duplex imaging strategy after endovenous interventions and implications for (over)diagnosis of endovenous heat induced thrombus (EHIT)
Speaker: | lowell kabnick, Lake Worth, United States |
09:45 - 09:50
Audience participation and discussion
09:50 - 09:55
Medical adhesive system versus ablation with endothermal laser or radiofrequency for saphenous vein incompetence: a comparison of utilisation of adjunctive phlebectomy
Speaker: | Kathleen Gibson, Bellevue, United States |
09:55 - 10:00
Audience participation and discussion
Coffee - Networking break
10:00-10:30
Time: 10:00 - 10:30
Deep Venous Challenges
Time: 10:30 - 12:30
Anchor: | Sophie Renton, London, United Kingdom |
Moderators: | Armando Mansilha, Porto, Portugal |
Manj Gohel, Cambridge, United Kingdom |
10:30 - 10:35
Venoplasty technique and tips for treatment of venous obstruction and in-stent stenosis
Speaker: | Gerard O’Sullivan, Galway, Ireland |
10:35 - 10:40
Audience participation and discussion
10:40 - 10:45
Important factors for success in the development of new venous stents
Speaker: | Michael Lichtenberg, Arnsberg, Germany |
10:45 - 10:50
Audience participation and discussion
10:50 - 10:55
Defining ‘failure’ after deep venous stenting
Speaker: | Erin Murphy, Charlotte, United States |
10:55 - 11:00
Audience participation and discussion
11:00 - 11:05
Edited case: Venous recanalization for occluded IVC filter
11:05 - 11:10
Audience participation and discussion
11:10 - 11:15
How to manage IVC filter retrieval: Straight forward and complex
Speaker: | Iain Wilson, Southampton, United Kingdom |
11:15 - 11:20
Audience participation and discussion
11:20 - 11:25
Deciding when inflow is inadequate for venous stenting
Speaker: | Houman Jalaie, Aachen, Germany |
11:25 - 11:30
Audience participation and discussion
11:30 - 11:35
Techniques for venous access and crossing occlusions in the treatment of venous outflow obstruction
Speaker: | Baris Ozdemir, Bristol, United Kingdom |
11:35 - 11:40
Audience participation and discussion
11:40 - 11:45
Advances in deep vein valve reconstruction
Speaker: | Ramon Varcoe, Randwick, Australia |
11:45 - 11:50
Audience participation and discussion
11:50 - 11:55
Edited Case: Hybrid endovascular and surgical bypass for post-thrombotic iliac occusive disease
Speaker: | Erin Murphy, Charlotte, United States |
11:55 - 12:00
Audience participation and discussion
12:00 - 12:05
When is removal of an inferior vena cava filter truly necessary in patients with post-thrombotic syndrome?
Speaker: | Kush Desai, Chicago, United States |
12:05 - 12:10
Audience participation and discussion
12:10 - 12:15
LUPA trial and the role of deep venous intervention in venous ulcer care
Speaker: | Stephen Black, London, United Kingdom |
12:15 - 12:20
Audience participation and discussion
12:20 - 12:25
Areas of consensus and discord between experts regarding deep venous interventions
Speaker: | Rick de Graaf, Friedrichshafen, Germany |
12:25 - 12:30
Audience participation and discussion
Lunch Break
12:30 - 13:30
Time: 12:30 - 13:30
Satellite Symposium
Time: 12:30 - 13:00
Deep Venous Challenges continued
13:30-15:30
Time: 13:30 - 14:10
Anchor: | Sophie Renton, London, United Kingdom |
Moderators: | Erin Murphy, Charlotte, United States |
Armando Mansilha, Porto, Portugal |
13:30 - 13:35
Stent shape, radial force, flow and clinical outcomes - is there any link?
Speaker: | Paul Gagne, Darien, United States |
13:35 - 13:40
Audience participation and discussion
13:40 - 13:45
Insights and lessons from observed deep venous stent migrations
Speaker: | Paul Chouinard, United States |
13:45 - 13:50
Audience participation and discussion
13:50 - 13:55
Podium First: CLEAR-DVT study results
Speaker: | Mitchell Silver, Columbus, United States |
13:55 - 14:00
Audience participation and discussion
14:00 - 14:05
Rationale for a move towards mechanical thrombus removal therapies and away from lysis
Speaker: | Emma Wilton, Beaconsfield, United Kingdom |
14:05 - 14:10
Audience participation and discussion
Lymphatic Challenges
Time: 14:10 - 15:00
14:10 - 14:15
Value of specific lymphatic imaging in patients with swollen legs
Speaker: | Kristiana Gordon, London, United Kingdom |
14:15 - 14:20
Audience participation and discussion
14:20 - 14:25
What the plastic surgeon can add to the care of patients with lymphoedema
Speaker: | Håkan Brorson, Haessleholm, Sweden |
14:25 - 14:30
Audience participation and discussion
14:30 - 14:35
The next generation of compression therapy to manage oedema and lymphoedema
Speaker: | Giovanni Mosti, LUCCA, Italy |
14:35 - 14:40
Audience participation and discussion
14:40 - 14:45
Non-surgical management of phlebolymphoedema and lymphoedema
Speaker: | Franz Schingale, Nurnberg, Germany |
14:45 - 14:50
Audience participation and discussion
14:50 - 14:55
The value of near infrared fluorescence lymphatic imaging in clinical practice
Speaker: | Sarah Thomis, Leuven, Belgium |
14:55 - 15:00
Audience participation and discussion
Pelvic Venous Challenges
Time: 15:00 - 15:30
15:00 - 15:05
Top-down versus bottom-up treatment for patients with pelvic origin varices
Speaker: | Aleksandra Jaworucka- Kaczorowska, Gorzow Wielkopolski, Poland |
15:05 - 15:15
Audience participation and discussion
15:15 - 15:20
Five unbreakable rules for good clinical outcomes after pelvic vein embolisation
Speaker: | Sriram Narayanan, Singapore, Singapore |
15:20 - 15:30
Audience participation and discussion
Tea - Networking break
15:30-16:00
Time: 15:30 - 16:00
Pelvic Venous Challenges continued
16:00 - 18:00
Time: 16:00 - 16:30
Anchor: | Sophie Renton, London, United Kingdom |
Moderators: | Stephen Black, London, United Kingdom |
Erin Murphy, Charlotte, United States |
16:00 - 16:05
Practical implications of the SVP classification for pelvic venous disorders
Speaker: | Mark Meissner, Seattle, United States |
16:05 - 16:10
Audience participation and discussion
16:10 - 16:15
Edited case: Tips and tricks for optimal pelvic venous embolisation
Speaker: | Sriram Narayanan, Singapore, Singapore |
16:15 - 16:20
Audience participation and discussion
16:20 - 16:25
Edited case: Treatment of pelvic origin leg and vulval varicosities
Speaker: | Aleksandra Jaworucka- Kaczorowska, Gorzow Wielkopolski, Poland |
16:25 - 16:30
Audience participation and discussion
Venous Wound Challenges
Time: 16:30 - 17:20
16:30 - 16:35
Implementing evidence-based pathways for venous ulceration
Speaker: | Alun Davies, London, United Kingdom |
16:35 - 16:40
Audience participation and discussion
16:40 - 16:45
Acceptance of endovenous interventions in patients with venous leg ulceration
Speaker: | Manj Gohel, Cambridge, United Kingdom |
16:45 - 16:50
Audience participation and discussion
16:50 - 16:55
Edited case: How to treat venous leg ulcers efficiently. How low can you go?
Speaker: | Leith Williams, Liverpool, United Kingdom |
16:55 - 17:00
Audience participation and discussion
17:00 - 17:05
Building optimal wound care centres for patients with leg ulceration
Speaker: | Arkadiusz Jawien, Bydgoszcz, Poland |
17:05 - 17:10
Audience participation and discussion
17:10 - 17:15
Edited Case: New venous stent procedure
Speaker: | Stephen Black, London, United Kingdom |
17:15 - 17:20
Audience participation and discussion
Venous Challenges and Hurting Leg
Time: 17:20 - 18:00
17:20 - 17:25
The difference between haemangiomas and vascular malformations
Speaker: | Fiona Rohlffs, Hamburg, Germany |
17:25 - 17:30
Audience participation and discussion
17:30 - 17:35
Vascular venous involvement malformation causing hurting leg
Speaker: | Jocelyn Brooks, London, United Kingdom |
17:35 - 17:40
Audience participation and discussion
17:40 - 17:45
Fact and fiction around the use of compression stockings for the prevention of venous thromboembolism
Speaker: | Joseph Shalhoub, London, United Kingdom |
17:45 - 17:50
Audience participation and discussion
17:50 - 17:55
Thrombotic implications of Covid-19 infection and vaccination for venous interventions
Speaker: | Ismail Elalamy, Paris, France |
17:55 - 18:00
Audience participation and discussion